LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/16/2026
Back to search
Official data from USPTO
ADAC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADAC
ST13
US500000079322105Class
1, 5, 10, 42
Filing
79322105
Registration
6970291
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/17/2026
Trademark type
Word
Nice classes
1, 5, 10, 42
Filing date
08/24/2021
Registration date
02/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2023
Last transaction
04/17/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
SE
Examiner
HAN, DAWN L
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Strike Pharma AB
Representatives
Donna J. Bunton NIXON & VANDERHYE P.C.
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry for production of antibodies and synthetic and natural peptides
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunologyoncologyimmuno-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunologyoncologyimmune-oncologydiabetesautoimmunologydermatologygynecologyurologygastroenterology and ophthalmology
Class 10
Delivery systems in the nature of implantable drug delivery ports for the deferredcontrolled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes
Class 42
Research and development within the biologicalpharmacologicalveterinarymicrobiologicalbiomedicalpharmabioticalbiotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies
Publications
History of USPTO decisions and trademark events.
29 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/30/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/08/2023
FIMP
FINAL DISPOSITION PROCESSED
05/08/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/22/2022
PUBO
PUBLISHED FOR OPPOSITION
11/22/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/02/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/28/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/17/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/25/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/25/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/25/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/31/2022
RFNT
REFUSAL PROCESSED BY IB
04/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/18/2022
RFRR
REFUSAL PROCESSED BY MPU
03/18/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/17/2022
CNRT
NON-FINAL ACTION WRITTEN
02/16/2022
DOCK
ASSIGNED TO EXAMINER
02/07/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
10/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/08/2021
Continuous trademark protection
Get notified about every new filing that threatens ADAC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.